A Novel Heptamethine Cyanine Photosensitizer for FRET-amplified Photodynamic Therapy and Two-Photon Imaging in A-549 Cells.

Jing Liu,Lingfeng Wang,Ronghua Shen,Jie Zhao,Ying Qian
DOI: https://doi.org/10.1016/j.saa.2022.121083
IF: 4.831
2022-01-01
Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy
Abstract:In this study, a new cyanine-based photosensitizer Cy-N-Rh was developed for photodynamic therapy. Based on fluorescence resonance energy transfer (FRET) mechanism, utilizing the absorption of the donor rhodamine (Rh), the acceptor heptamethine cyanine unit (Cy) was indirectly excited to produce singlet oxygen (O-1(2)). The efficiency of energy transfer from the donor Rh to the acceptor Cy was 78.5%. Meanwhile, the singlet oxygen yield of Cy-N-Rh (Phi(delta) = 12.00%) was much higher than that of the acceptor Cy (Phi(delta) = 4.35%) without FRET. Moreover, the dual cation gave Cy-N-Rh with excellent mitochondria targeting ability with Pearson's correlation coefficients of 0.90 and 0.91, respectively. In the MTT test, Cy-N-Rh had low dark cytotoxicity with cell survival rate above 90% and high photo cytotoxicity with cell survival rate below 40%. The cell apoptosis assay also demonstrated the role of the photosensitizer Cy-N-R visually. More importantly, Cy-N-Rh fulfilled two-photon excitation fluorescence imaging under the 800 nm femtosecond laser. All results indicate that this design strategy provides a new method for the development of higher-level cyanine photosensitizers. (C) 2022 Elsevier B.V. All rights reserved.
What problem does this paper attempt to address?